Impax Asset Management (UK)’s Thermo Fisher Scientific TMO Stock Holding History

Impax Asset Management (UK)’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.05M	Buy	+5,088	New	+$1.08M	0.03%	61
2017 Q3	–	Sell	-290,801	Closed	-$50.7M	–	54
2017 Q2	$50.7M	Buy	290,801 +59,005	+25%	+$9.91M	1.7%	25
2017 Q1	$35.6M	Buy	231,796 +18,264	+9%	+$2.79M	1.47%	30
2016 Q4	$30.2M	Buy	213,532 +18,075	+9%	+$2.66M	1.33%	32
2016 Q3	$31.1M	Buy	195,457 +1,241	+0.6%	+$191K	1.43%	26
2016 Q2	$28.7M	Buy	194,216 +21,218	+12%	+$3.13M	1.43%	30
2016 Q1	$24.5M	Sell	172,998 -4,302	-2%	-$577K	1.31%	31
2015 Q4	$25.2M	Buy	177,300 +15,000	+9%	+$2M	1.57%	23
2015 Q3	$19.9M	Buy	162,300 +42,400	+35%	+$5.52M	1.38%	30
2015 Q2	$15.6M	Buy	119,900 +27,400	+30%	+$3.57M	0.98%	39
2015 Q1	$12.4M	Buy	92,500 +37,600	+68%	+$4.85M	0.82%	40
2014 Q4	$6.89M	Buy	+54,900	New	+$6.68M	0.46%	47
2014 Q3	–	Sell	-30,600	Closed	-$3.62M	–	46
2014 Q2	$3.62M	Buy	+30,600	New	+$3.6M	0.23%	40
2014 Q1	–	Sell	-10,400	Closed	-$1.16M	–	44
2013 Q4	$1.16M	Hold	10,400	–	–	0.11%	41
2013 Q3	$960K	Sell	10,400 -51,712	-83%	-$4.68M	0.1%	41
2013 Q2	$5.26M	Buy	+62,112	New	+$5.17M	0.63%	35

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Impax Asset Management (UK)'s TMO Position: Q2 2018 in Review

Impax Asset Management (UK) opened a new position in Thermo Fisher Scientific (TMO) in Q2 2018: 5,088 shares worth $1.05M. The stake represents 0.03% of the portfolio and ranks #61 among its holdings. This is a return to the name: Impax Asset Management (UK) previously reported a position in TMO as recently as Q2 2017.

Impax Asset Management (UK) first reported a position in TMO in Q2 2013 and has held it in 16 quarters since. The position peaked at $50.7M in Q2 2017. 1,322 funds tracked by Wall St. Rank hold TMO as of Q2 2018.

Impax Asset Management (UK) held 5,088 shares of Thermo Fisher Scientific worth $1.05M as of Q2 2018.
Thermo Fisher Scientific was a new Impax Asset Management (UK) position in Q2 2018.
Thermo Fisher Scientific made up 0.03% of Impax Asset Management (UK)'s portfolio in Q2 2018, its #61 holding.
Impax Asset Management (UK) first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 16 quarters since.
Impax Asset Management (UK)'s Thermo Fisher Scientific position peaked at $50.7M in Q2 2017.
1,322 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2018.

Based on Impax Asset Management (UK)'s 13F filing for Q2 2018, filed 14 Aug 2018.